Arevalo-Perez, J.; Trang, A.; Yllera-Contreras, E.; Yildirim, O.; Saha, A.; Young, R.; Lyo, J.; Peck, K.K.; Holodny, A.I.
Longitudinal Evaluation of DCE-MRI as an Early Indicator of Progression after Standard Therapy in Glioblastoma. Cancers 2024, 16, 1839.
https://doi.org/10.3390/cancers16101839
AMA Style
Arevalo-Perez J, Trang A, Yllera-Contreras E, Yildirim O, Saha A, Young R, Lyo J, Peck KK, Holodny AI.
Longitudinal Evaluation of DCE-MRI as an Early Indicator of Progression after Standard Therapy in Glioblastoma. Cancers. 2024; 16(10):1839.
https://doi.org/10.3390/cancers16101839
Chicago/Turabian Style
Arevalo-Perez, Julio, Andy Trang, Elena Yllera-Contreras, Onur Yildirim, Atin Saha, Robert Young, John Lyo, Kyung K. Peck, and Andrei I. Holodny.
2024. "Longitudinal Evaluation of DCE-MRI as an Early Indicator of Progression after Standard Therapy in Glioblastoma" Cancers 16, no. 10: 1839.
https://doi.org/10.3390/cancers16101839
APA Style
Arevalo-Perez, J., Trang, A., Yllera-Contreras, E., Yildirim, O., Saha, A., Young, R., Lyo, J., Peck, K. K., & Holodny, A. I.
(2024). Longitudinal Evaluation of DCE-MRI as an Early Indicator of Progression after Standard Therapy in Glioblastoma. Cancers, 16(10), 1839.
https://doi.org/10.3390/cancers16101839
